228 related articles for article (PubMed ID: 1348537)
1. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
Holmes BB; Fujimoto JM
J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
[TBL] [Abstract][Full Text] [Related]
2. Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1993 Oct; 46(2):331-9. PubMed ID: 7903457
[TBL] [Abstract][Full Text] [Related]
3. Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A.
Aksu F; Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1993 Jun; 45(2):409-18. PubMed ID: 8101007
[TBL] [Abstract][Full Text] [Related]
4. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
Arts KS; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1992 May; 261(2):643-51. PubMed ID: 1374471
[TBL] [Abstract][Full Text] [Related]
5. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
Rady JJ; Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
[TBL] [Abstract][Full Text] [Related]
6. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).
Fujimoto JM; Holmes B
J Pharmacol Exp Ther; 1990 Jul; 254(1):1-7. PubMed ID: 1973192
[TBL] [Abstract][Full Text] [Related]
7. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
Fujimoto JM; Rady JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
[TBL] [Abstract][Full Text] [Related]
9. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the antianalgesic action of dynorphin A in mice by cholera toxin.
Arts KS; Fujimoto JM; Crain SM
Pharmacol Biochem Behav; 1993 Nov; 46(3):623-9. PubMed ID: 7904072
[TBL] [Abstract][Full Text] [Related]
11. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
Wang FS; Fujimoto JM
J Pharmacol Exp Ther; 1993 Jun; 265(3):1361-8. PubMed ID: 8099619
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice.
Holmes BB; Fujimoto JM
Anesth Analg; 1993 Dec; 77(6):1166-73. PubMed ID: 7902680
[TBL] [Abstract][Full Text] [Related]
13. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
14. Elimination of the antianalgesic action of dynorphin A by spinal transsection in barbital-anesthetized mice.
Wang FS; Rady JJ; Fujimoto JM
J Pharmacol Exp Ther; 1994 Feb; 268(2):873-80. PubMed ID: 7906735
[TBL] [Abstract][Full Text] [Related]
15. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
16. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
Rady JJ; Holmes BB; Fujimoto JM
Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
[TBL] [Abstract][Full Text] [Related]
17. Clonidine, administered intracerebroventricularly in mice, produces an anti-analgesic effect which may be mediated spinally by dynorphin A (1-17).
Fujimoto JM; Arts KS
Neuropharmacology; 1990 Apr; 29(4):351-8. PubMed ID: 1971432
[TBL] [Abstract][Full Text] [Related]
18. Nociceptin and dynorphin A(1-17) produce antianalgesia through independent systems in mice.
Rady JJ; Fujimoto JM
Life Sci; 2002 Jan; 70(9):1085-93. PubMed ID: 11860156
[TBL] [Abstract][Full Text] [Related]
19. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
Song ZH; Takemori AE
Life Sci; 1991; 48(15):1447-53. PubMed ID: 1672725
[TBL] [Abstract][Full Text] [Related]
20. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
